Company intelligence / Profile preview

TRX Medical Devices

Leeds/Garforth area, West Yorkshire, United Kingdomtrxtraining.com ↗

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Tissue Regenix has commercialized its regenerative implants in Europe, notably OrthoPure® XT, which received CE mark approval for knee ligament repair and began shipments in December 2020. The company is pursuing clinical data for further regulatory reviews and expanding its distribution network.

Therapeutic areas: NeurologyDermatologyOphthalmologyCardiovascularOtherWomen's Health
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Partnerships

White label manufacturing agreement with a top ten global healthcare company for soft tissue orthopaedic product launchDistribution partners secured across UK and PolandFurther partnerships under discussion across Europe

Beyond the preview

Go deeper on TRX Medical Devices.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRX Medical Devices.

Explore the full profile